Compounds And Compositions for the Treatment of Ocular Disorders
申请人:Graybug Vision, Inc.
公开号:US20170080092A1
公开(公告)日:2017-03-23
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.
Dynamic Kinetic Resolution of α-Substituted β-Ketoesters Catalyzed by Baeyer-Villiger Monooxygenases: Access to Enantiopure α-Hydroxy Esters
作者:Ana Rioz-Martínez、Aníbal Cuetos、Cristina Rodríguez、Gonzalo de Gonzalo、Iván Lavandera、Marco W. Fraaije、Vicente Gotor
DOI:10.1002/anie.201103348
日期:2011.8.29
BVMOs make a play: The dynamic kineticresolution of racemic α‐alkyl‐β‐ketoesters was performed through a selective Baeyer–Villiger oxidation employing different Baeyer–Villigermonooxygenases (BVMOs) in mild basic media. The product diesters were obtained with excellent yields and enantioselectivities, and used as precursors for optically active α‐hydroxy esters.
Modifying oligoalanine conformation by replacement of amide to ester linkage
作者:Takahiro Hongen、Tohru Taniguchi、Kenji Monde
DOI:10.1002/chir.22823
日期:2018.4
a rigid left‐handed helical structure. In this study, oligo(lactic acid) was incorporated into oligoalanine sequences and their conformations were studied by vibrational circular dichroism and electronic circular dichroism spectroscopy. The results suggested that oligo(lactic acid) moiety in these sequences maintains a left‐handed helix and increases the conformational propensity of the oligoalanine
Compounds and compositions for the treatment of ocular disorders
申请人:Graybug Vision, Inc.
公开号:US10159747B2
公开(公告)日:2018-12-25
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.